APOTEX TECHNOLOGIES INC.;THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA;MICHAEL SPINO;JOSHUA LAWRENCE DUNAIEF
发明人:
申请号：
IL21429111
公开号：
IL214291A
申请日:
2011.07.26
申请国别(地区):
IL
年份:
2015
代理人:
摘要：
There is provided use of orally available or topically applied deferiprone for prevention of iron-induced eye damage. The use may be for preparation of a medicament or in a method of preventing iron-induced eye damage to an eye of a subject at risk for iron-induced eye damage, the method comprising administering a prophylactically effective amount of deferiprone to the subject. There is also provided the use of deferiprone for treatment of iron-related eye disorders. The use may be for preparation of a medicament or in a method of treatment of damage to an eye of a having eye damage associated with iron, the method comprising topically administering a therapeutically effective amount of deferiprone to the subject.
